Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials

BACKGROUND AND AIMS: Extraintestinal manifestations [EIMs] such as arthritis/arthralgia are common in inflammatory bowel disease. We performed post hoc analyses of data from the GEMINI studies to evaluate the effect of vedolizumab, a gut-selective anti-trafficking agent, on arthritis/arthralgia. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Feagan, Brian G, Sandborn, William J, Colombel, Jean-Frédéric, Byrne, Sharon O’, Khalid, Javaria M, Kempf, Christian, Geransar, Parnia, Bhayat, Fatima, Rubin, David T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302953/
https://www.ncbi.nlm.nih.gov/pubmed/30203005
http://dx.doi.org/10.1093/ecco-jcc/jjy125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302953/
https://www.ncbi.nlm.nih.gov/pubmed/30203005
http://dx.doi.org/10.1093/ecco-jcc/jjy125

Ejemplares similares